Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Aaysha Cader Profile picture
@aayshacader
May 20, 2021 • 7 tweets • 9 min read • Read on X
Scrolly
#EuroPCR Physiology-guided imaging case of stagedPCI to RCA in a patient with MVD from Imperial
- now in the Main Arena
@rallamee @SukhNijjer

@ANazmiCalik @ShaziaTHussain1 @ShrillaB @TharushaGunawa4 @NicolaRyanI1 @AsherElad @Ortega_Paz @ezmanshariff @DrAllenJ @mirvatalasnag
#EuroPCR Setting up the Omniwire for physiologic assessment

@PCRonline
#EuroPCR @PCRonline
Recording normalization ⤵️
Demonstration of physiologic assessment of ostial RCA lesion: use of buddy wire.
#EuroPCR
🟣NOW in the main arena!🟣
Important discussions around MDT, offering surgery in MVD in diabetics and physiologic assessment
#EuroPCR @SukhNijjer @rallamee @ncurzen
Incredible 1st case of Omniwire in Europe & demonstration of how physiology changed approach

Great discussions by @SukhNijjer @ncurzen @rallamee et al.
Important takeaway from @rallamee : Don't just rely on you eyes- assess for ischaemia with physiology
#EuroPCR @PCRonline
Your*

• • •

Missing some Tweet in this thread? You can try to force a refresh
　

Keep Current with Aaysha Cader

Aaysha Cader Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @aayshacader

Aaysha Cader Profile picture
Dec 4, 2021
Such an important topic!Sex-related eligibility criteria leading to exclusion of women from clinical trials. @hvanspall proposes pragmatic eligibility criteria facilitating enrolment of women &URM in RCTs
#CVCT2021 @CVCTForum @SantosGallegoMD @DrRaniKhatib @drdargaray
Brilliant slide by @hvanspall on strategies to increase diversity in clinical trials
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @Drroxmehran @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela
@FaiezZANNAD on geographic equity in CV clinical trials:increasing research capacity & trial enrolment in LMIC Case in point:MENA region
#CVCT2021 @CVCTForum @docbhardwaj @DjawidHashemi @DrRaniKhatib @hvanspall @DrRajivsankar @drdargaray @DVervoort94 @mirvatalasnag @Hragy
Read 17 tweets
Aaysha Cader Profile picture
Dec 4, 2021
Dominick Angiolillo on the dilemma of perioperative antiplatelet therapy
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @rachkataria @FaiezZANNAD @drdargaray @ShahzebKhanMD @DVervoort94 @SolovevaAnzhela @cristina_gavina
Some great insights on limitations of perioperative antiplatelet Rx & limitations of guidelines - the issue perioperative antiplatelet and HBR are not the same! #CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @DrRajivsankar @FaiezZANNAD @DLBHATTMD
Basic concepts on bridging antiplatelets and why #cangrelor is best suited
#CVCT2021 @CVCTForum @docbhardwaj @SantosGallegoMD @AHajduczok @DrRaniKhatib @hvanspall @DrRajivsankar @mirvatalasnag @SuzanneJBaron @DLBHATTMD @Pooh_Velagapudi @sabeedak1 @SABOURETCardio
Read 7 tweets
Aaysha Cader Profile picture
Dec 4, 2021
The regulatory viewpoint of endpoints in antithrombotic therapy trials by Ellis Unger #CVCT #iCVCT @docbhardwaj @DrRajivsankar @DrRaniKhatib @SantosGallegoMD @CMichaelGibson @hvanspall @CVCTForum @rachkataria @lucreciamburgos @AHajduczok @Drroxmehran @djc795 @A_FelixOliveira
The regulatory viewpoint of endpoints in antithrombotic therapy trials by Ellis Unger #CVCT2021 @docbhardwaj @DrRajivsankar @DrRaniKhatib @SantosGallegoMD @CMichaelGibson @hvanspall @CVCTForum @rachkataria @lucreciamburgos @AHajduczok @DjawidHashemi @BoldiKovacsMD @ZainabDakhil2
How different should anti XIa trials be: @CMichaelGibson weighs in on population, endpoints, duration of therapy, disease states?
#CVCT2021 @docbhardwaj @DrRajivsankar @DrRaniKhatib @SantosGallegoMD @CMichaelGibson @hvanspall @CVCTForum @rachkataria @lucreciamburgos @AHajduczok
Read 4 tweets
Aaysha Cader Profile picture
Dec 3, 2021
#ICPeeps next up: the first session of #iCVCT #CVCT2021 on hemodynamic support trials with ⭐ panel
@alaide_chief @NavinKapur4 @thiele_holger @georgedangas et al.

@CVCTForum @Drroxmehran @CMichaelGibson @mirvatalasnag @ShrillaB @Babar_Basir @adityadoc1 @DrRaniKhatib @ShrillaB
Despite ESC recommendations IABP remains most widely used MCS in Germany: European perspectives and trends in MCS by @alaide_chief
#CVCT #iCVCT @NavinKapur4 @thiele_holger @georgedangas @CVCTForum @Drroxmehran @ShrillaB @Babar_Basir @adityadoc1 @DrRaniKhatib @docbhardwaj
Heterogenic use of #MCS in Europe dictated by country specific policies, cost and availability
@alaide_chief
#CVCT #iCVCT @NavinKapur4 @thiele_holger @georgedangas @CVCTForum @Drroxmehran @hvanspall @rachkataria @AHajduczok @DrRajivsankar @DrRaniKhatib @SantosGallegoMD
Read 10 tweets
Aaysha Cader Profile picture
Dec 2, 2021
fantastic takeaway slides on subgroup analyses & secondary results publications by @FaiezZANNAD
#CVCT2021 @hvanspall @DjawidHashemi @rachkataria @SantosGallegoMD @AlexNowbar @DrRajivsankar @cristina_gavina @A_FelixOliveira @BoldiKovacsMD @docbhardwaj @drdargaray ImageImage
Dr Joseph Hill @CircAHA on the nuances and challenges with publishing artificial intelligence analyses of trial databases:
#CVCT2021 @hvanspall @rachkataria @SantosGallegoMD @AlexNowbar @DrRajivsankar @cristina_gavina @A_FelixOliveira @BoldiKovacsMD @docbhardwaj @drdargaray ImageImageImage
@cardiobrief Larry Husten raises an important issue; should trials be released to the press before full publication is available?
#CVCT2021 @hvanspall @rachkataria @SantosGallegoMD @AlexNowbar @CVCTForum @drdargaray @DrRajivsankar @DrRaniKhatib @AHajduczok
Read 5 tweets
Aaysha Cader Profile picture
Aug 30, 2021
#ESCCongress When coronary angiography is not enough: @RaberLorenz turns on the light with #OCT –
🔦ACS-⬆️resolution of OCT -gold standard to ID thrombus, ID unclear culprit, ACS aetiology, rule-in & rule-out
🔦#MINOCA
🔦Stent thombosis
🔦Optimize PCI
@mirvatalasnag @Hragy
Phenomenal talk oy @MaeharaAkiko : SCenarios where #IVUSis gold-standard

#ESCCongress @sbrugaletta @ziadalinyc @SanjogKalra @NishithChandra @APSIC6 @w_jyg @DrAnkushG @care4urheart2 @ShrillaB @chadialraies @cardioPCImom @ANazmiCalik @GeminaDB @KVM83 @ShaziaTHussain1
#ESCCongress
@JEscaned on physiologic assessment in guiding PCI

@adityadoc1 @DrAllenJ @SukhNijjer @Pooh_Velagapudi @adityadoc1 @poojaotherwise @KardiologieHH @w_jyg @NishithChandra @sabeedak1 @SanChris999 @skilicmd @APSIC6 @chadialraies @dranulala @Ortega_Paz @sbrugaletta
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

Send Email!

:(